InfraRed Imaging Systems, Inc.
Co. is now launching an imaging device that allows clinicians to accurately and efficiently insert needles/catheters in veins and arteries.
INRIS is launching its VascularViewer, an imaging device for vascular access that increases efficiency, lowers costs, reduces pain, and improves quality of care. Reaction to the product has been excellent from hospitals well aware of competitive products. Device and disposable are highly profitable from launch. Break-even is projected in 1 year. Seeking final Angel investment of $1.25MM. Projected IRR is 92% on exit via trade sale in 5 years.